Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 4401 - 4425 of 6491 in total

3,5-Dinitrocatechol

Experimental

UDP-6-sulfoquinovose

Experimental
Matched Iupac: … [(2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan …

3,5-Difluoroaniline

Experimental

2,5-di-tert-butylhydroquinone

Experimental

TP-252

TP-252 consists of magnesium L-lysinate bis-eicosapentaenoate, an ionizable salt of eicosapentaenoic acid (EPA), currently being investigated to treat familial adenomatous polyposis.
Investigational

4,5-Dimethyl-1,2-phenylenediamine

Experimental

Afasevikumab

Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).
Investigational

3D-185 free base

Investigational

Pterostilbene

Investigational

Tinlarebant

Investigational

2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE

Experimental

2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide

Experimental

Omega-6 fatty acids

Omega-6 fatty acids are polyunsaturated fatty acids with a final carbon-carbon double bond in the n-6 position, that is, the sixth bond, counting from the methyl end. They are a family of fatty acid molecules that act as precursors to potent lipid mediator signalling molecules with either pro-inflammatory and anti-inflammatory...
Nutraceutical

(2R,4S)-2-[(1R)-1-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid

Experimental

1,3,5-Trimethoxybenzene

Experimental

Exon 55 specific phosphorothioate oligonucleotide

Investigational

Visometin cation

Investigational

ONCOS-102

Investigational

4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid

Experimental

4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL

Experimental

Tagetitoxin

Tagetitoxin is a bacterial phytotoxin. It preferentially inhibits eukaryotic RNA polymerase.
Experimental

Quinalizarin

Experimental

Tideglusib

Tideglusib is under the investigation for the development of treatments for Alzheimer's disease and for progressive supranuclear palsy. It is reported to be a potent anti-inflammatory and neuroprotective that is a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3). Tideglusib is being developed by the Spanish pharmaceutic company Zeltia...
Investigational
Withdrawn

Uridine-Diphosphate-N-Acetylgalactosamine

Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[( …

Uridine-Diphosphate-N-Acetylglucosamine

Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[( …
Displaying drugs 4401 - 4425 of 6491 in total